Home/Filings/4/0000899243-20-007098
4//SEC Filing

Sheehy Douglas T. 4

Accession 0000899243-20-007098

CIK 0001631650other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 9:38 PM ET

Size

6.0 KB

Accession

0000899243-20-007098

Insider Transaction Report

Form 4
Period: 2020-03-02
Transactions
  • Tax Payment

    Common Stock, $0.0001 par value

    2020-03-02$23.81/sh3,960$94,28852,958 total
Footnotes (4)
  • [F1]The reported sale was made pursuant to a pre-determined election to sell shares to cover tax withholding obligations in connection with the vesting of a previously reported equity award.
  • [F2]Includes 11,250 restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest in three successive, equal, annual installments measured from March 1, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
  • [F3]Includes 9,375 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
  • [F4]Includes 21,492 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Issuer

Aimmune Therapeutics, Inc.

CIK 0001631650

Entity typeother

Related Parties

1
  • filerCIK 0001488637

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 9:38 PM ET
Size
6.0 KB